MRN specializes in the conduct of clinical trial visits in the patient’s home and supporting clinical trial sites with nursing resources. We believe in reducing the burden of participation on patients and reducing the burden on participation on sites - building more patient-centric clinical trials.
MRN offers two core services in the management of complex clinical trials:
Home Trial Support (HTS) is the conduct of clinical trial visits in the patient’s home. This replaces a number of protocol defined visits which would normally take place onsite, and relocates them in the patient’s home – reducing the burden of the trial on the patient and significantly boosting patient recruitment and maximizing patient retention. With HTS, sites can recruit patients from a wider geographical region and reach a larger patient pool, as well as increase their consenting and retention rates. We have seen that reducing the burden on patients directly increases recruitment by 60% or more and typically maintains patient retention at over 95%, as well as reducing the burden on clinical sites.
Site Nurse Support (SNS) places experienced research nurses into sites to manage trials; this enables each site to focus on patient identification and selection, as well as facilitating performance of all procedures in a timely manner. Placements can be made at single sites, or nursing teams can be pulled together to support sites across whole countries or trials. With SNS, sites have a dedicated resource to identify and screen patients from the increased patient pool effectively.
Together, the impact of these services can result in an increase of up to 600% of completed patients per site.
MRN is a recognized leader in the Home Trial Support clinical trials field. We have a geographical coverage of over 40 countries where we can provide our services. Headquartered in the UK and with offices in North America and Spain, our Vendor Contracts and Management Team (VCMT) have enabled us to conduct Home Trial support visits across all major clinical research countries spanning North America, Europe, Asia and Australasia
MRN build global Site Network – expanding patient access to clinical trials in new communities. August 29, 2024 5:21am
MRN build global Site Network – expanding patient access to clinical trials in new communities. Milton Keynes (29 August 2024) – Today, UK based Medical Research Network (MRN), the innovative market-leader of international community-based clinical trial delivery, announces the launch of their rapidly-growing global site network. Known for their in-home trial delivery and on-site resource […]
The post MRN build global Site Network – expanding patient access to clinical trials...
View this post
Finding the Win-Win-Win, for Sites, Patients, and Sponsors August 15, 2024 8:32am
Imagine a world where 80% of clinical trials recruit on time, where patient centricity is integral, access to research is inclusive and equitable and sites are fully armed for success. Surely this isn’t rocket science? Yet still today, in 2024, traditional trials are sub optimal. 85% trials do not deliver on time and cause costly […]
The post Finding the Win-Win-Win, for Sites, Patients, and Sponsors appeared first on MRN.
View this post
Ensuring quality of in-home trial delivery while reducing participation burden. July 30, 2024 1:46pm
Ensuring quality of in-home trial delivery while reducing participation burden. There are several challenges that hybrid trial models aim to address one challenge is that protocols are increasingly complex & demanding leading to enrollment barriers & retention challenges. Hybrid trials alleviate these challenges by reducing patient and site burden when participating in a clinical trial. […]
The post Ensuring quality of in-home trial delivery while reducing participation burden. app...
View this post
Do Community Based Trials Actually Improve Patient Access? July 8, 2024 4:56am
Do Community Based Trials Actually Improve Patient Access? I only have MRN data to go on – so this is all based on MRN internal analytics. There are some external references listed at the end for context. We are regularly told sites using our services achieve 50% increased recruitment or more. Here’s is what we […]
The post Do Community Based Trials Actually Improve Patient Access? appeared first on MRN.
View this post
Growth Drivers for DCTs in the next 5 years June 26, 2024 10:58am
Growth Drivers for DCTs in the next 5 years The global DCT market was estimated at $7.71 billion in 2022 and is expected to reach $18.29 billion by 2028. The key areas of focus to drive that growth will be: The push to design adaptable, faster trial models: The industry needs to access larger cohorts […]
The post Growth Drivers for DCTs in the next 5 years appeared first on MRN.
View this post
What challenges can we mitigate for trial sites? June 25, 2024 10:14am
A reflection from SCRS West After attending SCRS West in early June, I left feeling quite sympathetic to many of the burdens sites face in today’s environment. While there has been an enormous push towards patient centricity and viewing patients as partners, there seems to be less of a push in supporting sites as partners. […]
The post What challenges can we mitigate for trial sites? appeared first on MRN.
View this post
